What makes your innovation unique?
The Cell-Chip-Group at Vienna University of Technology is revolutionising drug development for neurodegenerative diseases through innovative research. Patient-specific brain tissue models are used to precisely test drugs and thereby enable personalised therapies. With the aim of preserving quality of life so that people can continue to enjoy their passions.
Advantages
• Precise measurements due to miniaturised reaction chambers
• Rapid development of personalised treatments
• Supporting the vitality of an increasingly ageing population
About the company
Founded in 1815, Vienna University of Technology is Austria's largest technical research and educational institute. Top-level research is performed at eight faculties with five specialisations as over 26,000 students benefit from 62 degree programmes. The institute promotes innovation, strengthens the economy and contributes to social prosperity.
